Stockholder Alert: Robbins LLP Informs Investors of the Fractyl Health, Inc. Class ActionMorningStar·2 days ago, 08:00 PMGUTS-1.92%
Fractyl Health spotlights REMAIN-1 data showing Revita maintains 84% of GLP-1 weight loss in optimized cohortPUBT·Aug 20 at 06:18 AMGUTS-1.92%
Fractyl Health to host virtual Commercial Strategy Day on Revita go-to-market planPUBT·Aug 20 at 06:04 AMGUTS-1.92%
Fractyl Health Eyes Q4 Revita Data, Launches Rejuva Gene Therapy TrialMarket Beat·Aug 14 at 04:04 AMGUTS-1.92%
Fractyl Health Helps Maintain Weight After Stopping Popular Obesity Drugs, Stock Soarsbenzinga_article·Jul 15 at 01:22 PMGUTS-1.92%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Jul 15 at 12:05 PMCRDF+15.90%SNTI-14.82%
Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation | GUTS Stock NewsStockTitan·Jul 14 at 09:00 PMGUTS-1.92%
